These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2538230

  • 21. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
    Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I.
    Cancer Res; 1988 Feb 01; 48(3):650-3. PubMed ID: 3335027
    [Abstract] [Full Text] [Related]

  • 22. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.
    Jourdan M, Tarte K, Legouffe E, Brochier J, Rossi JF, Klein B.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):65-70. PubMed ID: 10210775
    [Abstract] [Full Text] [Related]

  • 23. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism.
    Matthews N, Neale ML, Jackson SK, Stark JM.
    Immunology; 1987 Sep 01; 62(1):153-5. PubMed ID: 3653925
    [Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.
    Feinman R, Henriksen-DeStefano D, Tsujimoto M, Vilcek J.
    J Immunol; 1987 Jan 15; 138(2):635-40. PubMed ID: 3098851
    [Abstract] [Full Text] [Related]

  • 25. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC, Harlan JM, Adamson JW.
    J Immunol; 1987 Jun 15; 138(12):4298-302. PubMed ID: 3495589
    [Abstract] [Full Text] [Related]

  • 26. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia.
    Barton MH, Bruce EH, Moore JN, Norton N, Anders B, Morris DD.
    Am J Vet Res; 1998 Jun 15; 59(6):792-7. PubMed ID: 9622754
    [Abstract] [Full Text] [Related]

  • 27. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 28. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
    Liddil JD, Dorr RT, Scuderi P.
    Cancer Res; 1989 May 15; 49(10):2722-8. PubMed ID: 2713856
    [Abstract] [Full Text] [Related]

  • 29. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD, Bird A, Hutzler D, Montgomery W.
    Exp Hematol; 1987 Oct 15; 15(9):928-35. PubMed ID: 2820776
    [Abstract] [Full Text] [Related]

  • 30. Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells.
    Walker DH, Popov VL, Crocquet-Valdes PA, Welsh CJ, Feng HM.
    Lab Invest; 1997 Jan 15; 76(1):129-38. PubMed ID: 9010456
    [Abstract] [Full Text] [Related]

  • 31. Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical.
    Varani J, Fligiel SE, Till GO, Kunkel RG, Ryan US, Ward PA.
    Lab Invest; 1985 Dec 15; 53(6):656-63. PubMed ID: 2999509
    [Abstract] [Full Text] [Related]

  • 32. Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.
    McIntosh JK, Mulé JJ, Merino MJ, Rosenberg SA.
    Cancer Res; 1988 Jul 15; 48(14):4011-7. PubMed ID: 3260130
    [Abstract] [Full Text] [Related]

  • 33. Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies.
    Grau GE, Vesin C, De Groote D, Delacroix D, Gysler C, Piguet PF, Lambert PH.
    Clin Exp Immunol; 1991 Jun 15; 84(3):411-4. PubMed ID: 2044219
    [Abstract] [Full Text] [Related]

  • 34. Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.
    Hauser GJ, McIntosh JK, Travis WD, Rosenberg SA.
    Cancer Res; 1990 Jun 15; 50(12):3503-8. PubMed ID: 2340500
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the influence of recombinant human tumor necrosis factor on adhesive ability of human fetal umbilical vein endothelial cells to K562 and L1210 cells.
    Barilka VA, Matlan VL, Prymak SV, Loginsky VY.
    Exp Oncol; 2013 Dec 15; 35(4):313-7. PubMed ID: 24382444
    [Abstract] [Full Text] [Related]

  • 36. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line.
    Raitano AB, Korc M.
    J Biol Chem; 1990 Jun 25; 265(18):10466-72. PubMed ID: 2141333
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term effect of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells.
    Raitano AB, Scuderi P, Korc M.
    Int J Pancreatol; 1990 Mar 25; 6(2):109-18. PubMed ID: 2121855
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.
    Kosaka T, Kuwabara M, Koide F.
    J Vet Med Sci; 1992 Apr 25; 54(2):275-9. PubMed ID: 1606257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.